India Equity Analysis, Reports, Recommendations, Stock Tips and more!
Search Now
Recommendations
Showing posts with label Sun Pharma. Show all posts
Showing posts with label Sun Pharma. Show all posts
Sunday, April 13, 2014
Tuesday, April 08, 2014
Monday, April 07, 2014
Thursday, April 03, 2014
Thursday, August 16, 2012
Wednesday, February 15, 2012
Sunday, November 20, 2011
Sunday, October 23, 2011
Thursday, October 13, 2011
Sunday, September 25, 2011
Tuesday, August 02, 2011
Friday, April 15, 2011
Sunday, February 06, 2011
Sun Pharmaceuticals
The ongoing correction is a good opportunity to add the blue-chip Sun Pharmaceuticals stock to your portfolio. At the current market price of Rs 418, the stock trades at about 20 times its likely FY-12 per share earnings. While this may leave little headroom for the stock price to appreciate in the near term, the likely improvement in the financials of Taro, robust product pipeline and strong balance-sheet with $845 million (about Rs 3800 crore) cash on books suggest strong growth prospects. On-time launches of generic Eloxatin, Prandin and Taxotere in the US too could act as positive triggers for the stock.
Thursday, February 03, 2011
Wednesday, February 02, 2011
Tuesday, February 01, 2011
Tuesday, December 28, 2010
Saturday, December 25, 2010
Subscribe to:
Posts (Atom)